RepliCel Life Sciences Inc (REPCF)
0.0428
0.00 (0.00%)
USD |
OTCM |
Mar 27, 16:00
RepliCel Life Sciences Market Cap: 2.785M for March 27, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 27, 2024 | 2.785M |
March 26, 2024 | 2.785M |
March 25, 2024 | 2.785M |
March 22, 2024 | 2.785M |
March 21, 2024 | 2.785M |
March 20, 2024 | 2.785M |
March 19, 2024 | 2.785M |
March 18, 2024 | 2.785M |
March 15, 2024 | 2.785M |
March 14, 2024 | 2.652M |
March 13, 2024 | 2.652M |
March 12, 2024 | 3.026M |
March 11, 2024 | 3.026M |
March 08, 2024 | 2.610M |
March 07, 2024 | 2.925M |
March 06, 2024 | 2.925M |
March 05, 2024 | 2.925M |
March 04, 2024 | 2.600M |
March 01, 2024 | 2.717M |
February 29, 2024 | 2.587M |
February 28, 2024 | 2.587M |
February 27, 2024 | 3.226M |
February 26, 2024 | 3.114M |
February 23, 2024 | 3.114M |
February 22, 2024 | 3.114M |
Date | Value |
---|---|
February 21, 2024 | 3.114M |
February 20, 2024 | 2.652M |
February 16, 2024 | 2.652M |
February 15, 2024 | 2.399M |
February 14, 2024 | 3.237M |
February 13, 2024 | 3.023M |
February 12, 2024 | 3.023M |
February 09, 2024 | 3.023M |
February 08, 2024 | 3.279M |
February 07, 2024 | 2.912M |
February 06, 2024 | 3.247M |
February 05, 2024 | 3.247M |
February 02, 2024 | 2.802M |
February 01, 2024 | 2.555M |
January 31, 2024 | 2.808M |
January 30, 2024 | 3.140M |
January 29, 2024 | 3.140M |
January 26, 2024 | 3.140M |
January 25, 2024 | 3.140M |
January 24, 2024 | 3.140M |
January 23, 2024 | 3.530M |
January 22, 2024 | 3.530M |
January 19, 2024 | 3.530M |
January 18, 2024 | 2.737M |
January 17, 2024 | 2.802M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.372M
Minimum
Oct 02 2020
12.93M
Maximum
Feb 09 2021
6.161M
Average
5.850M
Median
Oct 16 2023
Market Cap Benchmarks
Acasti Pharma Inc | 31.96M |
Aurinia Pharmaceuticals Inc | 723.09M |
Edesa Biotech Inc | 14.11M |
Lexaria Bioscience Corp | 38.72M |
InMed Pharmaceuticals Inc | 2.101M |
Market Cap Related Metrics
PS Ratio | 8.989 |
Price | 0.0428 |
Earnings Yield | -0.44% |
Normalized PE Ratio | 4.319 |